Novel Techsciences

Novel Techsciences is an India-based private company focused on AI-enabled and computational drug discovery. Publicly available descriptions indicate that it develops in silico tools to identify and predict therapeutic drug targets and has been associated with early research on phytochemical inhibitors for inflammatory and SARS-CoV-2-related targets. The company appears to operate from Kolkata, West Bengal, and was founded in 2019 by Shabaaz Solanki. Available evidence suggests it is a very early-stage, privately held discovery-platform business rather than a clinical-stage therapeutics company. There is no clear evidence of marketed products, clinical trials, major financing rounds, or broad partnered pipeline advancement.